How are we different from the big CROs?
You know your team
We are small team whose passion is clinical research.
There is no staff turnover, we are there for you all the time!
Every project is important
It does not matter if you have 1 study or 10 studies, you get the same level of attention from our team.
Your project is important for us.
If you are running small study it will be more cost effective to have a small team to do everything for you.
We are not afraid of new technologies
We learn quickly and we are happy to use new software and systems as per our clients needs.
We love working with people
We enjoy meeting and supporting all these lovely people working at the hospitals.
Relationship with sites is very important for us.
Free Email Consultation
Planning your first study in UK but do not know where to start? We are here to help you. Contact us for free consultation and advice.
Supporting our clients` success
Your project is important for us!
B cell receptor is involved in the normal B cell development and immunity but also in supporting the growth and survival of malignant B cells in patients with B cell leukaemias or lymphomas. The expression of this receptor on the surface of the B cells is important...
A research team from National Center for Nanoscience and Technology, Beijing, China has reported an interesting and novel approach in targeting tumours. They have constructed autonomous DNA robots which were programmed to transport and deliver therapeutics directly to...
FDA extends access to experimental drugs FDA extended access program started back in 2009 and it allowed patients with life-threatening diseases who have exhausted all other options to try experimental drugs, which are not on the market yet. After the implementation...
Circulating tumour cells (CTCs) are rare tumor cells that have been investigated for diagnostic, prognosis and predictive biomarkers for different types of cancer. CTCs have been described back in 1869. They are not used in clinical practice at the moment, however...
Children often have the same diseases as adults, however many of the approved drugs on the market are not tasted in children. Many rare and serious diseases affecting children have no treatment options and as a result clinicians are forced to use “off label” drugs...
Circular RNAs (circRNAs) are class of long, non-coding RNAs, which are very tissue specific. Initially these circRNAs were thought to have no biological function. In the recent research there are more and more evidence that these types of RNA are present in mammalian...
Cancer immunotherapy is a promising field in drug development because it provides new treatment options for various cancers, especially in combination with standard of care. Immune system can recognize and eliminate tumour cells and is responsible for targeting most...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.